Takahiro Miyamoto

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Sequential Treatment Strategy Using Fluoropyrimidine plus Bevacizumab Followed by Oxaliplatin for Metastatic Colorectal Cancer: A Phase II Study (OGSG 1107).

Sequential Treatment Strategy Using Fluoropyrimidine plus Bevacizumab Followed by Oxaliplatin for Metastatic Colorectal Cancer: A Phase II Study (OGSG 1107).

Journal: Gastrointestinal tumors

Published: August 12, 2021

The Management of Recurrence of Hepatocellular Carcinoma Occurring Within 6 Months After Hepatic Resection: A Comparative Study Using a Propensity Score Matching Analysis.

The Management of Recurrence of Hepatocellular Carcinoma Occurring Within 6 Months After Hepatic Resection: A Comparative Study Using a Propensity Score Matching Analysis.

Journal: Journal of gastrointestinal cancer

Published: January 11, 2021

Safety and Efficacy of Laparoscopic Liver Resection for Colorectal Liver Metastasis With Obesity.

Safety and Efficacy of Laparoscopic Liver Resection for Colorectal Liver Metastasis With Obesity.

Journal: The American surgeon

Published: December 07, 2020

Pharmacokinetics of Dexamethasone when Administered with Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting and Differences in Dose-Dependent Antiemetic Effects.

Pharmacokinetics of Dexamethasone when Administered with Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting and Differences in Dose-Dependent Antiemetic Effects.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: November 24, 2020

Retrospective Comparison of mFOLFOXIRI With XELOX/SOX as Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.

Retrospective Comparison of mFOLFOXIRI With XELOX/SOX as Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.

Journal: In vivo (Athens, Greece)

Published: October 29, 2020

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: July 26, 2019

IL33 Is a Key Driver of Treatment Resistance of Cancer.

IL33 Is a Key Driver of Treatment Resistance of Cancer.

Journal: Cancer research

Published: July 19, 2019

Chemoradiotherapy for Local Recurrence of Rectal Cancer: A Single Center Study of 18 Patients.

Chemoradiotherapy for Local Recurrence of Rectal Cancer: A Single Center Study of 18 Patients.

Journal: In vivo (Athens, Greece)

Published: May 02, 2019

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.

Journal: BMC cancer

Published: March 13, 2019

Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer.

Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer.

Journal: ESMO open

Published: January 07, 2019

III. The Review of JSCCR Guidelines 2016 for the Treatment of Colorectal Cancer

III. The Review of JSCCR Guidelines 2016 for the Treatment of Colorectal Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: November 16, 2017

Efficacy of Prophylactic G-CSF in Patients Receiving FOLFIRINOX: A Preliminary Retrospective Study.

Efficacy of Prophylactic G-CSF in Patients Receiving FOLFIRINOX: A Preliminary Retrospective Study.

Journal: Internal medicine (Tokyo, Japan)

Published: December 04, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026